paeonol has been researched along with Idiopathic Parkinson Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wu, S; Ye, M; Yi, Y; Zhao, D; Zhou, Y | 1 |
Geng, ZM; Hu, ZW; Wang, H; Wang, SY; Zhao, B | 1 |
Chen, YH; Liu, H; Qu, HD; Shi, X | 1 |
3 other study(ies) available for paeonol and Idiopathic Parkinson Disease
Article | Year |
---|---|
Role of Paeonol in an Astrocyte Model of Parkinson's Disease.
Topics: Acetophenones; Animals; Apoptosis; Astrocytes; Cell Survival; Cyclooxygenase 2; Disease Models, Animal; Dopaminergic Neurons; Extracellular Signal-Regulated MAP Kinases; Mice; Models, Biological; Neuroprotective Agents; Nitric Oxide Synthase Type II; Parkinson Disease; Signal Transduction; Substantia Nigra; Up-Regulation | 2017 |
[Neuroprotective effects of paeonol in a cell model of Parkinson disease].
Topics: 1-Methyl-4-phenylpyridinium; Acetophenones; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Survival; Down-Regulation; Fluoresceins; Neuroprotective Agents; Parkinson Disease; PC12 Cells; Proto-Oncogene Proteins c-bcl-2; Rats; Reactive Oxygen Species | 2015 |
Therapeutic effects of paeonol on methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid-induced Parkinson's disease in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acetophenones; Animals; Behavior, Animal; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Dopaminergic Neurons; Drugs, Chinese Herbal; Immunohistochemistry; Male; Mice; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Probenecid; Rotarod Performance Test; Tyrosine 3-Monooxygenase | 2016 |